Resideo Technologies, Inc. (REZI)
NYSEIndustrialsIndustrial - DistributionSnapshot 2026-10-30
$18.73-0.37%
Close 2026-10-30 · 1-day change
NYSEIndustrialsIndustrial - DistributionSnapshot 2026-10-30
Research Workspace
Put REZI beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Trading Companies & Distributors: fringe margins under pressure (4q confirmed)
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Sustain revenue growth near $7.85 billion in 2026: Comparison needs review.
View ThesisRevenue growth is slowing — up about 3% over the past year and decelerating.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 18%, softest on free-cash-flow yield.
View QualityManagement screens weak on capital allocation, the balance sheet, market reaction to earnings.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 63% in its worst 12-month stretch.
View RiskREZI’s case rests on steady revenue, yet that growth is slowing and cash support remains weak. Q2 FY2026 revenue grew 2% year over year, though non-GAAP earnings beat consensus. REZI trades at 8× P/E versus a 24× peer median, below its 11× historical multiple. The price reflects less growth than our forecast, despite that valuation gap. The 32% next-quarter miss probability and fragile cash backing threaten the case. The thesis is on watch because its revenue comparison needs review. Peer multiples imply a price about 49% above where it trades; this read is provisional.
Trailing returns as of 2026-10-30. REZI is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 6 analysts currently covering REZI (as of Oct 2026).
Based on 3 Wall Street analysts offering 12-month price targets for REZI in the last 4 months.
Continue this research
Compare REZI with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| REZI Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 8 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Trading Companies & Distributors — fair value, gap to price, and forward P/E.
Compare the value case
Put REZI next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Threatens: Complete spin-off of ADI Global Distribution business
Analyst downgrade impacts perception of ADI spin-off success.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $18.73
The last 12 months of price, then the range of analyst 12-month targets from today’s $18.73.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Complete spin-off of ADI Global Distribution business
Confirms revenue expectations post ADI spin-off.
Advances: Increase revenue growth
Transformation efforts indicate strong revenue growth potential.
Advances: Improve operating income
Strong earnings suggest improved operating income.